Gender-specific outcomes in immune checkpoint inhibitor therapy for advanced or metastatic urothelial cancer: a systematic review and meta-analysis

PURPOSE: To analyze gender-specific differences in survival parameters in advanced or metastatic urothelial cancer patients undergoing immune checkpoint inhibition. METHODS: The primary aim of this systematic review and meta-analysis was to evaluate gender-specific differences in disease-free (DFS),...

Descripción completa

Detalles Bibliográficos
Autores principales: Schneidewind, Laila, Kiss, Bernhard, Zengerling, Friedemann, Borkowetz, Angelika, Graf, Sebastian, Kranz, Jennifer, Dräger, Desiree L., Graser, Annabel, Bellut, Laura, Uhlig, Annemarie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10374671/
https://www.ncbi.nlm.nih.gov/pubmed/37079051
http://dx.doi.org/10.1007/s00432-023-04788-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10374671/
https://www.ncbi.nlm.nih.gov/pubmed/37079051
http://dx.doi.org/10.1007/s00432-023-04788-x

Ejemplares similares